Literature DB >> 30970216

Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.

Lu Wan1,2, Tian Xia3, Yanqin Du4, Jie Liu1, Yuyu Xie1, Yijie Zhang1, Fei Guan1, Jun Wu4, Xiaochuan Wang2, Chunwei Shi1.   

Abstract

The mechanism of exosomes derived from activated hepatic stellate cells (HSCs) involved in liver fibrosis is poorly understood. We previously reported that hypoxia-inducible factor 1 (Hif-1) regulated HSC activation, and, therefore, we investigated in current work whether Hif-1 regulates exosome secretion and the metabolic switch of HSCs, thus affecting the metabolism of liver nonparenchymal cells. In this study, the characteristics of exosomes from HSCs were assessed via electron microscopy, Western blot analysis, and acetylcholinesterase activity. Confocal microscopy was used to measure the uptake of exosomes by quiescent HSCs, Kupffer cells (KCs), and liver sinusoidal endothelial cells (LSECs). Hif-1α was inhibited via 2-ME or specific small interfering RNAs to investigate its role in exosomes derived from HSCs. It was determined that glucose transporter 1 and pyruvate kinase M2 were increasingly expressed in fibrotic liver samples, cell lysates, and exosomes derived from activated HSCs. Exosomes released from HSCs were associated with activation and glucose uptake of HSCs. Delivery of exosomes from activated HSCs induced glycolysis of quiescent HSCs, KCs, and LSECs. Disruption of Hif-1 expression suppressed the glycolysis effect delivered by exosomes. Conclusively, our results demonstrated that exosomes secreted by activated HSCs affect the metabolic switch of liver nonparenchymal cells via delivery of glycolysis-related proteins. These findings represent a novel mechanism that contributes to liver fibrosis and has significant implications for new diagnosis and treatment of liver diseases.-Wan, L., Xia, T., Du, Y., Liu, J., Xie, Y., Zhang, Y., Guan, F., Wu, J., Wang, X., Shi, C. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.

Entities:  

Keywords:  Hif-1; glycolysis; hepatic fibrosis

Mesh:

Substances:

Year:  2019        PMID: 30970216     DOI: 10.1096/fj.201802675R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  41 in total

Review 1.  Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.

Authors:  Shutao Zheng; Qing Liu; Tao Liu; Xiaomei Lu
Journal:  J Physiol Biochem       Date:  2021-04-09       Impact factor: 4.158

Review 2.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 3.  The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.

Authors:  Wei Du; Lin Wang
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

Review 4.  Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease.

Authors:  Chanbin Lee; Jinsol Han; Youngmi Jung
Journal:  Biology (Basel)       Date:  2022-04-21

Review 5.  Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases.

Authors:  Mrigya Babuta; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2021-11-10       Impact factor: 6.011

6.  Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.

Authors:  Dandan Zheng; Yuchuan Jiang; Chen Qu; Hui Yuan; Kaishun Hu; Lu He; Peng Chen; Jinying Li; Mengxian Tu; Lehang Lin; Hengxing Chen; Zelong Lin; Wenyu Lin; Jun Fan; Guohua Cheng; Jian Hong
Journal:  Am J Pathol       Date:  2020-08-15       Impact factor: 4.307

Review 7.  The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells.

Authors:  Parth Trivedi; Shuang Wang; Scott L Friedman
Journal:  Cell Metab       Date:  2020-11-23       Impact factor: 27.287

8.  Sunitinib and Axitinib increase secretion and glycolytic activity of small extracellular vesicles in renal cell carcinoma.

Authors:  Aaron R Lim; Benjamin G Vincent; Alissa M Weaver; W Kimryn Rathmell
Journal:  Cancer Gene Ther       Date:  2021-06-04       Impact factor: 5.854

9.  PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.

Authors:  Junxia Feng; Meizhi Lu; Wenhao Li; Jingchun Li; Ping Meng; Zukai Li; Xuejuan Gao; Yunfang Zhang
Journal:  Mol Cell Biochem       Date:  2022-04-05       Impact factor: 3.842

Review 10.  Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.

Authors:  David R Brigstock
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.